Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cl Lam

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Translational Respiratory Medicine|May 29, 2016
Oncogenic driver mutations in lung cancerSusan Y Luo, David Cl Lam
Substance Abuse Treatment, Prevention, and Policy|September 2, 2025
Tobacco and asthma: presenting the world health organization (WHO) tobacco knowledge summaryWenying Lu, Sarah Rylance, Kerstin Schotte, et al.
BMC Pulmonary Medicine|May 14, 2024
SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese populationLydia Wy Fung, Vincent Kc Yan, Christine Kwan, et al.
Oncotargets and Therapy|February 6, 2015
Oncogenic mutation profiling in new lung cancer and mesothelioma cell linesDavid Cl Lam, Susan Y Luo, Wen Deng, et al.
Respiratory Research|September 11, 2024
Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge SummaryWenying Lu, Rebekka Aarsand, Kerstin Schotte, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Translational Respiratory Medicine|May 29, 2016
Oncogenic driver mutations in lung cancerSusan Y Luo, David Cl Lam
Substance Abuse Treatment, Prevention, and Policy|September 2, 2025
Tobacco and asthma: presenting the world health organization (WHO) tobacco knowledge summaryWenying Lu, Sarah Rylance, Kerstin Schotte, et al.
BMC Pulmonary Medicine|May 14, 2024
SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese populationLydia Wy Fung, Vincent Kc Yan, Christine Kwan, et al.
Oncotargets and Therapy|February 6, 2015
Oncogenic mutation profiling in new lung cancer and mesothelioma cell linesDavid Cl Lam, Susan Y Luo, Wen Deng, et al.
Respiratory Research|September 11, 2024
Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge SummaryWenying Lu, Rebekka Aarsand, Kerstin Schotte, et al.
Pageof 1